RE:RE:RE:RE:RE:RE:RE:RE:RE:True? Crop buying out 1933?Cautiously optimistic at $0.43.
The evaluation is always fluid... while we have some positive macro events (US election cycle, Nov. earnings, sector legalization) and some positive micro events (CBD lab, infused expansion, AMA expansion), we also have 50% of the current share structure outstanding (240mm issued with 120mm reserved).
To MC lid is getting heavier by the day. The next couple of moves by management are critical IMO.
JD2016 wrote: BB, I'm trying to ascertain whether you're bearish or bullish on this stock and if you don't mind, because I follow your intelligent contributions to this bullboard, please explain why you take this stance. Thank you. quote=BaitingBateman]I think on a retail front, many people are not 'warm' to the idea of investing in foreign markets. That's exactly what an MJ investment is for the average american investor - think of all of the 'couch' and passive investors that make up the canadian retail landscape that all of a sudden became active, self-directed investors when they started playing around in the CDN MJ capital market.
I think there will be substantial, mainstream retail interest once US capital markets are opened to the small / mid-cap players. Federal banking and taxation regulation will be a big step.
As far as valuations go - understand that it is a completely different environment. The speculative component is completely removed from the equation. Real companies in real markets with real limits and real revenues. Yes, it is a growth market, yes, valuations will see inflations as a result of potential, but I do not think we'll see blatant disregard for fundamentals in the US marketplace.
Mangler85 wrote: Whoops and yes I missed banks.
Strongly believe this will be one of the main focusses too much cash floating around that is “tax money”
What’s ur opinion in the hype of banks getting in and the taboo if investing in mj being
removed in the US? Example the valuations of Canadian companies vs their revenues.
.
BaitingBateman wrote: You got it on a couple of fronts.
Realized revenue will not be reflected on the books until Q3 or Q4 of 2019.
Best case scenario is recreational cannabis as a states-rights issue - adress banking and taxation on a federal level and keep the doors on the marketplace from everybody and anybody wanting to operate.
Mangler85 wrote: near term CataList are clearly hype based as they will need time to roll out to really see the revenues .
So let’s go by your opinion that Republicans take the next election at midterms. Most likely they will federally legalize medical cannabis but they will probably leave recreational to a state-by-state choice.in my opinion the recreational product will not cross state borders and Nevada will Most likely have the highest profit margin’s per gram in the states.
BaitingBateman wrote: Is there anything speculative about a fully legalized recreational marking in NV? So why would a company be valued on a forward-looking basis?
$100mm MC is the equivalent of a 5:1 price to sales value - which, is actually quite healthy.
Financials will not be as impressive as you think. YE (or Q4) will capture the period of time from May through to the end of July. From Brayden's latest interview, they are just now almost hitting a $20mm run-rate. As of October, they are below $5mm / qt.
Q4 will be in the $3.75-4.25mm range, likely on the lower end.
gwizard wrote: I agree, this company is surprisingly quiet. Given the production potential here that is due to come online in a very short while, I cant wrap my head around why this is trading at only a 100 million market cap. Financial will be impressive, no doubt about that, but we need more. Brayden needs to promote the company and he promised to do so during the Reddit AMA. We are about to expand bigtime and yet we trade at this ridiculous price? Isn't the market forward looking? How patient do we need to be? I'm also surprised no one has made a hostile bid for this company at this price, but what the heck do I know.
[/quote]